TransGenic Group 2342.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 2342.T. It has been listed since 10 December 2002. In the fiscal year to 31 March 2026, it reported revenue of ¥13.17bn and a net loss of ¥77.3m. At that date it held total assets of ¥9.74bn and shareholders' equity of ¥4.78bn.

Trans Genic Inc. engages in the development, distribution, and licensing of genetically engineered animals and antibodies. The company is headquartered in Fukuoka, Fukuoka-Ken. The company went IPO on 2002-12-10. The firm has three business segments. The Contract Research Organization (CRO) segment is engaged in the provision of contract clinical tests for pharmaceuticals and foods, pharmacodynamic pharmacology tests, safety pharmacology tests, pharmacokinetic tests, and non-clinical tests such as safety tests for pesticides and food, the contract production of genetically modified mice and antibody, the sale of model mice, as well as the development of new biomarkers. The Diagnostic Analysis segment is engaged in the provision of pathological diagnosis services, gene analysis contract services, and drug discovery support services for individualized medicine. The TGBS segment is engaged in the provision of advice and support services for business succession and revitalization in various fields, as well as the electronic commerce (EC) business such as the retail and wholesale of electrical products.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Kenji FukunagaPresident, Chief Executive Officer, President of Subsidiaries, Representative Director, since 2009
• Mr. Kazuo WatanabeDirector of Accounting and Finance, Director, since 2017
• Mr. Yutaka FunabashiManager of IR & Corporate Management, Manager of Information Management, Director, since 2011
• Mr. Shunichi KitajimaChief Director of CRO Business, Manager of Facility Operation, Manager of Facility Operations in Main Group Administration, Director, since 2015
• Mr. Koji TakashimaDirector
• Mr. Akihito TomitaDirector
• Mr. Kenichi YamamuraDirector, since 2002
• Mr. Hotaka SaitoIndependent Director
• Mr. Tsutomu SeitoIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.